Detalhe da pesquisa
1.
Clinical targeting of HIV capsid protein with a long-acting small molecule.
Nature
; 584(7822): 614-618, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32612233
2.
Mechanistic characterization of GS-9190 (Tegobuvir), a novel nonnucleoside inhibitor of hepatitis C virus NS5B polymerase.
Antimicrob Agents Chemother
; 55(9): 4196-203, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21746939
3.
Substituted imidazopyridines as potent inhibitors of HCV replication.
J Hepatol
; 50(5): 999-1009, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19303654
4.
Design of a gene family screening library targeting G-protein coupled receptors.
J Mol Graph Model
; 23(1): 15-21, 2004 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15331050
5.
The HCV non-nucleoside inhibitor Tegobuvir utilizes a novel mechanism of action to inhibit NS5B polymerase function.
PLoS One
; 7(6): e39163, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22720059